These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25567215)

  • 1. Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF).
    D'Arcy DM; Corrigan OI; Deasy E; Gowing CM; Donnelly MB
    Eur J Clin Pharmacol; 2015 Mar; 71(3):377-8. PubMed ID: 25567215
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
    J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.
    D'Arcy DM; Casey E; Gowing CM; Donnelly MB; Corrigan OI
    BMC Pharmacol Toxicol; 2012 Nov; 13():14. PubMed ID: 23136834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Ahmed S; Thalhammer F
    J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration.
    Spooner AM; Deegan C; D'Arcy DM; Gowing CM; Donnelly MB; Corrigan OI
    BMC Clin Pharmacol; 2011 Aug; 11():11. PubMed ID: 21816053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
    Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
    J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
    Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
    J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive performance of a gentamicin population pharmacokinetic model in two western populations of critically ill patients.
    Bukkems LH; Roger C; Hodiamont CJ; Lefrant JY; Juffermans NP; Roberts JA; van Hest RM
    Int J Antimicrob Agents; 2018 Aug; 52(2):218-225. PubMed ID: 29704547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration.
    Malone ME; Corrigan OI; Kavanagh PV; Gowing C; Donnelly M; D'Arcy DM
    Int J Antimicrob Agents; 2013 Oct; 42(4):335-42. PubMed ID: 23920093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration.
    Yagasaki K; Gando S; Matsuda N; Kameue T; Ishitani T; Hirano T; Iseki K
    Intensive Care Med; 2003 Nov; 29(11):2094-5. PubMed ID: 14504724
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.
    Karaiskos I; Friberg LE; Galani L; Ioannidis K; Katsouda E; Athanassa Z; Paskalis H; Giamarellou H
    Int J Antimicrob Agents; 2016 Sep; 48(3):337-41. PubMed ID: 27474468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
    Lee B; Kim SJ; Park JD; Park J; Jung AH; Jung SH; Choi YH; Kang HG; Ha IS; Cheong HI
    PLoS One; 2018; 13(6):e0199158. PubMed ID: 29927988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.
    Ulldemolins M; Martín-Loeches I; Llauradó-Serra M; Fernández J; Vaquer S; Rodríguez A; Pontes C; Calvo G; Torres A; Soy D
    J Antimicrob Chemother; 2016 Jun; 71(6):1651-9. PubMed ID: 26869692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
    Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
    J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF).
    Gatti M; Rinaldi M; Tonetti T; Gaibani P; Siniscalchi A; Viale P; Pea F
    Int J Antimicrob Agents; 2023 Aug; 62(2):106852. PubMed ID: 37192727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous venovenous hemodiafiltration in critically ill patients with acute renal failure].
    Toft P; Felding M; Tønnesen EK
    Ugeskr Laeger; 2000 May; 162(20):2868-71. PubMed ID: 10860424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC; Saeed F; Kousar N; Burrill S; Barns B; Rickrode G; Fu J; Katrych O; Saunders-Hao P; Block C; Lahey T
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.
    Breilh D; Allaouchiche B; Jaumain H; Boulétreau P; Chassard D; Malbec I; Ducint D; Saux MC
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2409-11. PubMed ID: 10508016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.